Thymopentin vs Mifamurtide
Head-to-head comparison of Thymopentin (L-Arginyl-L-Lysyl-L-Aspartyl-L-Valyl-L-Tyrosine) and Mifamurtide (Muramyl Tripeptide Phosphatidylethanolamine) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Thymopentin | Mifamurtide |
|---|---|---|
| Category | Immune Support | Immune Support |
| Full Name | L-Arginyl-L-Lysyl-L-Aspartyl-L-Valyl-L-Tyrosine | Muramyl Tripeptide Phosphatidylethanolamine |
| Molecular Weight | 676.78 Da | N/A |
| Half-Life | 10-30 min | 2-4 h |
| Amino Acids | 5 | N/A |
| Typical Dose | 1 mg | 2 mg/m2 |
| Route | Subcutaneous | Intravenous |
| Purity | ≥98% | ≥98% |
| Studies Count | 90 | 150 |
| Research Status | Clinical | Clinical |
Thymopentin Benefits
- ✓t-cell maturation
- ✓helper-suppressor balance
- ✓immune recovery
- ✓antiviral-adjunct research
Mifamurtide Benefits
- ✓macrophage-activation
- ✓innate-immune-signaling
- ✓immune-adjuvant-research
- ✓cytokine-response
Thymopentin Dosing
1 mg SC or IM|2-3x weekly|4-8 week study cycles
Mifamurtide Dosing
2 mg/m2 IV|2x weekly for 12 weeks|then weekly for 24 weeks in approved regimens
Thymopentin Side Effects
- ⚠injection-site redness
- ⚠mild fever
- ⚠headache
Mifamurtide Side Effects
- ⚠fever/chills
- ⚠fatigue
- ⚠nausea
Research Overview
Thymopentin
Thymopentin has a long history of preclinical and clinical investigation as a thymic peptide immunomodulator. Published studies report effects on T-cell subsets, cytokine responses, and immune recovery in recurrent infection settings.
Mifamurtide
Mifamurtide has substantial literature as an innate immune activator and is an approved oncology adjunct in some regions. Research centers on NOD-like receptor signaling, macrophage activation, and downstream cytokine effects.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.